Table 2.

The difference in blood lipid and cardiovascular risk parameters between psoriasis with and without psoriatic arthritis and healthy controls

	PsA (n=136)	HC1 (n=136)	PsA vs HC1 p-value	PsO (n=152)	HC2 (n=152)	PsO vs HC2 p-value	PsA vs PsO p-value
ApoA1, g/L	1.08 (0.18)	1.21 (0.17)	<.0001	1.07 (0.18)	1.20 (0.16)	<.0001	.4496
ApoB, g/L	0.76 (0.15)	0.65 (0.13)	<.0001	0.70 (0.17)	0.60 (0.12)	<.0001	.0013
TC, mmol/L	4.95 (0.89)	4.82 (0.82)	.1939	4.61 (0.89)	4.56 (0.71)	.6033	.0013
TG, mmol/L	1.74 (1.13)	1.45 (1.07)	.0347	1.57 (1.02)	1.29 (0.86)	.0098	.1894
HDL-C, mmol/L	1.23 (0.32)	1.26 (0.26)	.3967	1.21 (0.29)	1.27 (0.27)	.037	.4731
LDL, mmol/L	3.06 (0.77)	2.83 (0.70)	.0115	2.84 (0.81)	2.67 (0.65)	.0405	.0229
Lp(a), mg/L	147.9 (158.0)	121.5 (138.8)	.1443	139.6 (175.2)	125.0 (150.0)	.4364	.6747
ApoB:ApoA1 ratio	0.72 (0.19)	0.55 (0.13)	<.0001	0.67 (0.19)	0.51 (0.13)	<.0001	.0208
TC:HDL ratio	4.21 (1.07)	3.94 (0.92)	.0227	3.98 (1.03)	3.73 (0.92)	.0261	.0603
LDL:HDL ratio	2.62 (0.82)	2.31 (0.67)	.0009	2.47 (0.85)	2.19 (0.71)	.0022	.1309
LDL:ApoB ratio	4.03 (0.59)	4.37 (0.69)	<.0001	4.08 (0.56)	4.41 (0.55)	<.0001	.4869

Abbreviation: ApoA1 apolipoprotein A1, ApoB apolipoprotein B, HC healthy controls, HDL-C high-density lipoprotein-cholesterol, LDL low-density lipoprotein, Lp(a) lipoprotein A, PsA psoriatic arthritis, PsO psoriasis without arthritis, TC total cholesterol, TG triglyceride

Mann-Whitney test, unpaired t test, and unpaired t test with Welch correction were used when appropriate. p < .025 is considered to be statistically significant